MILESTONE

  • 2021

    March 25, Successfully listed on the STAR Market of the Shanghai Stock Exchange (SSE)

  • 2020

    Capacity reached a record high of 400 million

  • 2019

    Jan, MDSAP Approved FOB, Tropnin I, HIV registered in China. April, US FDA CLIA Waived and OTC Cleared for Drug Tests.

  • 2018

    Jan, flawlessly passed US FDA audit

  • 2017

    May, HCG registered in China. Got ISO13485:2016

  • 2016

    Korea GMP/Health Canada Approved. Got the Hi-Tech Enterprise Certificate

  • 2015

    Oct. USA FDA facility

  • 2014

    CE/ISO/CFDA Approved

  • 2012

    Developing Rapid Test

  • 2009

    Company Established